Government subsidies, R&D investment and innovation performance: analysis from pharmaceutical sector in China. - Jian Xu 018; Xiuhua Wang 007; Feng Liu 066 (Technol. Anal. Strateg. Manag., 2021)

Do shareholders tolerate faults in scientific and technological innovation? Evidence from Chinese listed companies. - Xiuhua Wang 007; Jian Xu 018 (Technol. Anal. Strateg. Manag., 2023)